Maine DHHS/CDC releases mAb toolbox
- By: Danielle Watford
- On: 12/23/2021 10:11:34
- In: COVID-19
In response to advocacy efforts by MHCA on behalf of member homes Maine DHHS and CDC has released a toolkit to assist in administration of monoclonal antibody (mAb) therapies in congregate care facilities – i.e. LTC, ALFs, grp homes. The following are components of this introductory “Toolbox” for facilities to use when identifying residents eligible for such treatment. Included in the toolkit are:
2. List of relevant mAb providers for facilities
3. Eligibility “checklist” to help identify individuals appropriate for mAb therapies
4. Template info letter that facilities could send residents/families ahead of a COVID outbreak
5. FAQ/talking points on mAb therapies
As noted in the intro sheet, DHHS and Maine CDC expects that the indications and options for mAb therapies may change significantly in the coming weeks with the emergence of the omicron variant, but DHHS has committed to updating this toolbox as new information becomes available.
As the holidays approach we sincerely thank you for all you do and continue to do as this global pandemic drags on. In the words of the Grateful Dead, what a long strange trip it's been. We are here if you need support. Don't hesitate to reach out with questions, concerns or comments.
Staff Contact: email@example.com